SCHEMBL27353296

SCHEMBL27353296

C=CCOC(=O)c1ccc2cc(-c3ccc(OC)c(C45CC6CC(CC(C6)C4)C5)c3)ccc2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 10/20 0.70
RARG P13631 10/20 0.70
RARA P10276 7/20 0.70
MEN1 O00255 3/20 0.70
KMT2A Q03164 3/20 0.70
NR1I2 O75469 1/20 0.70
LMNA P02545 1/20 0.70
PGR P06401 1/20 0.70
HSPD1 P10809 1/20 0.70
GOT1 P17174 1/20 0.70
GLRA1 P23415 1/20 0.70
BLM P54132 1/20 0.70
HSPE1 P61604 1/20 0.70
TDP1 Q9NUW8 1/20 0.70
HDAC11 Q96DB2 4/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31456313 0.88 RARB (0.75) RARBRARGRARAMEN1KMT2A
SCHEMBL9502115 0.86 RARA (0.51) RARBRARGRARAMEN1KMT2A
SCHEMBL30698054 0.86 RARB (0.81) RARBRARGRARAMEN1KMT2A
SCHEMBL641921 0.86 RARB (0.81) RARBRARGRARAMEN1KMT2A
SCHEMBL9128086 0.84 RARA (0.51) RARBRARGRARAMEN1KMT2A
SCHEMBL24608833 0.84 RARB (0.78) RARBRARGRARAMEN1KMT2A
SCHEMBL8839137 0.83 RARA (0.50) RARBRARGRARAMEN1KMT2A
SCHEMBL9740004 0.83 RARA (0.49) RARBRARGRARAMEN1KMT2A
Adapalene SCHEMBL2747 0.82 RARB (1.00) RARBRARGRARAMEN1KMT2A
Adapalene SCHEMBL29357372 0.82 RARB (1.00) RARBRARGRARAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208922-A1 A TRIFLUOROMETHYL THIANTHRENIUM COMPOUND, PROCESS FOR PREPARING THE SAME AND THE USE THEREOF STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2024-06-27 US disclosed
US-20240208922-A1 A TRIFLUOROMETHYL THIANTHRENIUM COMPOUND, PROCESS FOR PREPARING THE SAME AND THE USE THEREOF STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2024-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208922-A1 A TRIFLUOROMETHYL THIANTHRENIUM COMPOUND, PROCESS FOR PREPARING THE SAME AND THE USE THEREOF CYP4F3, GTF3C3, GTF3C4 RARB 3367/4885RARG 3418/4885RARA 3031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.